Abstract
During an epidemic, the daily number of reported (infected/death) cases is often lower than the actual number of cases due to underreporting. Nowcasting aims to estimate the cases that have not yet been reported and combine it with the already reported cases to obtain an estimate of the daily cases. In this paper, we present a fast and flexible Bayesian approach to nowcasting combining P-splines and Laplace approximations. The main benefit of Laplacian-P-splines (LPS) is the flexibility and faster computation time compared to Markov chain Monte Carlo (MCMC) algorithms that are often used for Bayesian inference. In addition, it is natural to quantify the prediction uncertainty with LPS in the Bayesian framework, and hence prediction intervals are easily obtained. Model performance is assessed through simulations, and the method is applied to the Belgian COVID-19 mortality cases for the year 2021. Simulation results show that our model has good predictive performance except when the nowcast date is near the peak date, where it has lower prediction interval coverage.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project is funded by the European Union Research and Innovation Action under the H2020 work programme EpiPose (grant number 101003688).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data used is available on the website of the Sciensano research institute at https://epistat.sciensano.be/covid/covid19_historicaldata.html
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The raw data is available on the website of the Sciensano research institute at https://epistat.sciensano.be/covid/covid19_historicaldata.html. In addition, the cleaned version of the data is available on GitHub at https://github.com/bryansumalinab/Laplacian-P-spline-nowcasting.git.
https://github.com/bryansumalinab/Laplacian-P-spline-nowcasting.git
https://epistat.sciensano.be/covid/covid19_historicaldata.html